Formation of meningiomas has been associated with the loss of genetic material on chromosome 22. To approach the additional chromosomal events that underlie progression of these tumors to malignancy, we have examined several other chromosomal regions for loss of heterozygosity (LOH) in these tumors. Fifty-eight tumors, comprising 43 benign meningiomas, 11 atypical meningiomas and four malignant meningiomas, were examined. While the loss of chromosome 22 was seen in approximately half of all these tumors, regardless of their malignancy, the most frequent chromosomal losses observed in the malignant and atypical tumors were on the long arm of chromosome 14. Thirty-nine tumors were informative for at least one of the three markers on chromosome 14 that we tested. Of these, 7/14 malignant and atypical tumors showed LOH in contrast to only 1/ 25 benign tumors. Other loci that showed LOH in malignant tumors, although at a much lower frequency, were on chromosomes 17p and 1p. The high frequency of LOH for loci on chromosome 14q in atypical and malignant tumors suggests the presence of a tumor progression gene at this locus. In one of the malignant meningiomas heterozygosity was lost at D14S13 and D14S16 but retained at the proximal marker D14S43 as well as the more distal marker D14S23. This suggests that an interstitial deletion occurred in this tumor which should be useful for further re®ning the position of the putative tumor progression locus.
Introduction
Meningiomas comprise approximately 15% of all intracranial neoplasms and 25% of spinal cord tumors. They are thus one of the most common tumors of adults, with the age of incidence between 20 and 60 (Russell and Rubinstein, 1990) . These tumors generally occur as solitary tumors but multiple meningiomas have been described. They are thought to arise from the cells forming the outer layer of the arachnoid membrane, related cells such as arachnoidal ®broblasts, or undierentiated precursor cells of the meninges termed meningioblasts (Challa and Markesbery, 1992; Russell and Rubinstein, 1990) . Their pathology is subject to considerable variation, thus giving rise to controversies over the histogenesis and terminology of these tumors. Most meningiomas are slow growing, encapsulated tumors and are therefore often termed`benign'. Histologically they are characterized by a whorled pattern of cells and calci®ed structures known as psammoma bodies. A small fraction of meningiomas progress into a more aggressive, malignant form that can be distinguished from the`benign' meningioma by the absence of cellular architecture (referred to as`sheeting'), the presence of excessive mitotic activity, necrosis and invasion of neighboring tissue. Meningiomas that exhibit histological features that are in between those of`benign' and malignant meningiomas pose the most diculty in classi®cation as well as prognosis. These tumors are often referred to as`atypical' meningiomas.
The ®rst clues to ®nding genetic loci possibly involved in tumor initiation or progression in meningiomas and schwannomas were provided by cytogenetic studies that demonstrated loss of chromosome 22 as the most common chromosomal abnormality in these tumors (Zankl and Zang, 1972; Casalone et al., 1990) . Other investigators examined loci on chromosome 22 with polymorphic DNA markers and established that LOH on this chromosome was a common pathogenic mechanism for tumor formation in meningiomas as well as acoustic neuromas (Seizinger et al., 1986 (Seizinger et al., , 1987 Dumanski et al., 1987) .
To determine which additional chromosomal events were involved in the formation and/or progression of meningiomas we examined cytogenetic material from meningiomas to identify chromosomes that were lost or rearranged. The examination of cytogenetic material from meningiomas also suggested loss of chromosomes other than 22, indicating that other chromosomal regions might play a role in tumor formation and progression. We have examined VNTR markers on chromosomes 1, 2, 4, 9, 10, 14, 17, 19, 20 and 22 . In benign meningiomas LOH was seen on chromosome 22 (eight of 25 informative cases), chromosome 10 (three of 28 informative cases), chromosome 14 (one of 25 informative cases), and chromosome 19 (one of four informative cases) suggesting a chromosomal location for other genes involved in tumor formation. Our examination showed a signi®cant number of cases in which loss of chromosome 14 was observed.
Results
All tumors were graded by histopathological examination. Benign meningioma is characterized by the presence of whorls, ill de®ned cell borders, pale or sometimes optically empty intranuclear vacuoles, and psammoma bodies. These tumors generally do not show extensive mitoses, prominent nucleoli, or nuclear pleomorphism. Malignant meningioma is characterized by the presence of necrosis, increased cellularity, sheeting and nuclear pleomorphism, presence of mitoses, and invasion of surrounding tissue. Atypical meningioma comprises the group of meningiomas that show characteristics that are intermediate between benign and malignant such as moderate nuclear atypia with occasional prominent nucleoli, rare foci of necrosis, and scattered mitoses.
Genomic DNA from matched tumor and blood samples was digested with appropriate restriction enzymes, fractionated on agarose gels, and blotted onto nylon membranes. Blots were hybridized with radiolabeled probes. The chromosomal location of probes was con®rmed using in situ hybridization to chromosome preparations. The probes CMM101 and CKKA39 both displayed hybridization signals on distal chromosome 14q. No signal was detected for THH37 by in situ hybridization, therefore it was mapped using a panel of somatic cell hybrids by Southern blotting.
All tumors were ®rst tested for loss of chromosome 22. LOH on chromosome 22 was seen in roughly 30% (12 of 39) of the meningiomas regardless of the malignancy grade of the tumor, consistent with previous observations (Katsuyama et al., 1986; Seizinger et al., 1987; Casartelli et al., 1989) . The observation of chromosome 14 loss in karyotypes of meningiomas (Katsuyama et al., 1986; Casartelli et al., 1989) prompted us to use the highly polymorphic DNA markers CMM101 (D14S13), THH37 (D14S16) and CKKA39 (D14S23) to study LOH in these tumors. A total of 58 meningiomas was examined for LOH using matched DNA samples from tumor and peripheral lymphocytes. Based on the results of these matched DNA samples, 39 were informative with probes for at least three loci (Table 1 ). The set of informative tumors included in this study comprised 25 benign', 10 atypical and four malignant meningiomas. In order to determine whether additional deletion events occurred we also looked for LOH on 10 other chromosomal loci with the following polymorphic DNA markers: MLAJ1 (D1S61), MCT106 (D2S61), pYNZ32 (D4S23), DOSL5 (D9S1), EFD75 (D10S25), p5-1 (D10S1), pYNH 37.3 (D17S28), EFD4.2 (D19S22), CMM6 (D20S19) and NB129 (D22S193). Representative samples of the data obtained in ®ve matched tumor/ blood pairs with probes on chromosome 14 and 22 are shown in Figure 1 , and the summarized data on all 39 tumors are presented in Table 1 .
Of the`benign' tumors studied, LOH on chromosome 14 was seen in one of 25 informative events. Other chromosomal loci showing LOH were D9S1 (one of 14) and D19S22 (one of 12 informative cases). In contrast, four of 10 atypical meningiomas and three of four malignant meningiomas showed LOH for markers on chromosome 14. The other chromosomal loci lost in the higher grade tumors included D1S61 on chromosome 1p (two of seven informative cases) and D17S28 (two of seven informative cases). In all cases where markers on both chromosome 14 and chromosome 22 were heterozygous, LOH on chromosome 14 was paralleled by LOH on chromosome 22 (Figure 1 , cases 1 and 4). Overall, approximately 40% (six of 14) of the higher grade (atypical and malignant) meningiomas showed LOH on chromosome 14, whereas only one of 25`benign' meningiomas showed loss of these chromosome 14 markers. Three atypical/malignant tumors (cases 2, 3, and 5, Table 1 ) did not exhibit LOH for chromosome 22 but did exhibit LOH for chromosome 14. This is not unexpected since LOH for chromosome 22 is not required for tumor formation in the majority of meningiomas (Katsuyama et al., 1986) ; Seizinger et al., 1987; Casartelli et al., 1989) . Alternatively, the apparent retention of homozygosity could be explained if these loci were hemizygous in these cases.
One of the atypical meningiomas studied (Figure 2 , Case 6 and Figure 3) showed LOH on chromosome 14 with the markers D14S13 and D14S16, but apparently m a l i g n a n t m a l i g n a n t m a l i g n a n t Figure 1 Representative cases of atypical or malignant meningiomas in which LOH was observed with the markers CMM101 (D14S13), THH37 (D14S16) and CKKA39 (D14S23). The order of these markers on the long arm of chromosome 14 is based on the genetic linkage map of Nakamura et al. (1989) . Also shown (bottom panel) is an analysis of tumor and blood DNA from all ®ve cases using the chromosome 22 probe NB129 (D22S193). The faint residual signal is from blood and stroma in the tumor sample
Figure 2 Fine mapping of deletion on chromosome 14q. LOH was observed in a meningioma (Case 6) with the proximal markers CMM101 (D14S13) and THH37 (D14S16) but heterozygosity was retained at the distal marker CKKA39 (D14S23). LOH on chromosome 22 was observed in this patient using the marker NB129 (D22S193). Lanes containing tumor DNA are marked`T' and lanes containing matched control (blood) DNA are marked`B'. The faint residual signal is from blood and stroma in the tumor sample retained heterozygosity at the locus D14S23 (the closest anking locus on the telomeric side) suggesting the presence of an interstitial deletion on one copy of chromosome 14 in this tumor. While the extent of the deletion was clearly de®ned on the telomeric end by D14S23, it was dicult to precisely de®ne the boundary at the centromeric end. Several probes that have been placed centromeric to D14S13, such as pMZ9 (D14S18), or in the immediate vicinity of this locus, such as pCMM62 (D14S21), were uninformative in this tumor. The closest available informative marker on the centromeric side of the deletion was at the locus D14S43. This marker detected a dinucleotide polymorphism at D14S43 and has been described by Sharma et al. (1991) . The order of these markers on the long arm of chromosome 14 has been determined to be cen-D14S43-D14S13-D14S16-D14S23-tel (Nakamura et al., 1989; Hofker et al., 1990; NIH/CEPH Collaborative Mapping Group, 1992) . Consistent with our previous observations in malignant meningioma, this tumor also showed LOH of markers on chromosome 22 suggesting that the loss of the locus on chromosome 14 plays a role in the pathway towards malignancy rather than be the primary event in tumor initiation.
Discussion
The availability of highly polymorphic DNA markers and their use in LOH studies in tumors has allowed the identi®cation of many of the individual events that go into the formation of tumors and their progression towards malignancy (Marshall, 1991) . This approach has allowed the identi®cation of deletions on chromosome 22 as being the most common chromosomal event in the formation of meningiomas. The additional steps that are involved in the progression of these tumors from the`benign' to atypical and ®nally malignant stage have been the subject of this study. Of the polymorphic markers on 10 dierent chromosomes that were examined in high grade meningiomas (atypical and malignant tumors) the most frequent chromosomal losses were on chromosome 14 using the markers D14S13, D14S16 and D14S23. The observation of loss of this chromosome in meningiomas has been previously documented in studies of tumor karyotype, however many of these studies made the distinction only between`benign' (those that did not show frank invasion) and malignant meningiomas (those that showed frank invasion). The existence of a class of tumors, referred to as atypical meningiomas, that possess features intermediate between benign and malignant meningiomas poses a problem in the classi®cation of their grade causing them to generally be subsumed under the class of benign tumors. Our observation of chromosome 14 loss in atypical and malignant meningiomas would suggest that atypical meningiomas constitute a separate class, distinct from benign tumors. It will clearly be important to extend this study to see whether LOH on chromosome 14 in atypical meningiomas is a prognosis of future malignancy in these tumors.
The most frequently described chromosomal aberration of chromosome 14 in solid tumors is the loss of the entire chromosome. Loss of chromosome 14 has been described in meningioma (Katsuyama et al., 1986; Al Saadi et al., 1987) , neuroblastoma (Suzuki et al., 1989 ), Ewing's Sarcoma (Turc-Carel et al., 1988) and Leiomyosarcoma (Boghosian et al., 1989) . Furthermore, the description of chromosomal translocations that involve the same cytogenetic band on chromosome 14 suggest that a common genetic locus might be involved in the pathway towards tumorigenesis (Katsuyama et al., 1986; Al Saadi et al., 1987; Seizinger et al., 1987) as well as in other solid tumors such as neuroblastoma (Suzuki et al., 1989; Srivatsan et al., 1991) , breast tumors (Gebhart et al., 1986; Bello and Rey, 1989) , ovarian tumors (Atkin et al., 1990) , astrocytoma (Bigner et al., 1986) , retinoblastoma (Chaum et al., 1984) and malignant melanoma (Pedersen and Wang, 1989) . One malignant meningioma was identi®ed which showed loss of heterozygosity for the markers D14S13 (pCMM101) and D14S16 (THH37) but retention of heterozygosity for the proximal¯anking marker D14S23 or the distal anking marker D14S23. This further allows the placement of the putative tumor progression locus between D14S43 and D14S23 (assuming there were no terminal translocations in this tumor), a region encompassing the distal third of chromosome 14q. The cytogenetic placement of this locus is therefore between 14q24.3 and 14q32.3 (Nakamura et al., 1989; Sharma et al., 1991; NIH/CEPH Collaborative Mapping Group, 1992) , a region that contains the genes ELK-2, a member of the ETS family of oncogenes , AKT, a gene showing ampli®cation in gastric adenocarcinomas (Staal, 1987) , and the oncogene TCI-1 (Croce et al., 1985) . These genes are generally classi®ed as`proto-oncogenes' and are thought to play a role in tumor formation when they are activated by mutation or translocation (Croce et al., 1985; Staal, 1987; Rao et al., 1989) . It is not clear whether these genes can also act as tumor suppressors in other cell types. Experiments to test the expression of these genes in meningiomas might yield information on the role of these genes in tumor formation and progression. While the loss of chromosomal material on the long arm of chromosome 14 clearly indicates the presence of a tumor suppressor gene in this region, the apparent association of a higher grade of malignancy in meningiomas with loss of chromosome 14 in this study requires further study on a larger number of atypical and malignant meningiomas. It is possible that chromosome 14q24.3-32.3 harbors one of the genetic loci involved in the progression of meningiomas to malignancy in a manner similar to the multi-step mechanisms described in other cancers (Fearon and Vogelstein, 1990 ).
Materials and methods
DNA was extracted from tumors and corresponding normal tissue (peripheral blood). Tumor specimens were frozen on dry ice or liquid nitrogen immediately after surgery and were ground in a mortar to the consistency of a coarse powder. 0.5 g of this powder was resuspended in TNE-SDSProteinase K (10 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, 1% SDS, 200 mg/ml Proteinase K) and incubated overnight at 508C. DNA was isolated from peripheral blood lymphocytes by homogenizing peripheral venous blood in a solution containing 0.64 M sucrose, 20 mM Tris, 10 mM Magnesium chloride, 5% (v/v) Triton-X-100 pH 7.6 and then resuspending in TNE-SDS-Proteinase K overnight at 508C. DNA was puri®ed from these samples by phenol/chloroform extraction, precipitated with ethanol, and resuspended in TE (10 mM Tris pH 8.0, 1 mM EDTA). This DNA was digested with TaqI, PstI, or BglI (New England Biolabs) using conditions recommended by the manufacturer. The resulting DNA fragments were fractionated by agarose gel electrophoresis and transferred to Hybond N + membranes (Amersham) using the method of Southern (1975) . Southern blots were hybridized with probes for several polymorphic markers. The probe NB129 (D22S193) was a kind gift from Dr E Zwartho (Erasmus University, Rotterdam, The Netherlands). Probes pH35 (D22S44) and pH97b (D22S56) were kind gifts from Dr Beverly Emanuel (Children's Hospital, Philadelphia). Probes CMM101 (D14S13), THH37 (D14S16), CKKA39 (D14S23), MLAJ1 (D1S61), MCT106 (D2S61), pYNZ32 (D4S23), DOSL5 (D9S1), EFD75 (D10S25), p5-1 (D10S1), pYNH 37.3 (D17S28), EFD4.2 (D19S22), CMM6 (D20S19), pMS3-18 (D22S1), pEFZ31 (D22S32), and W22D (D22S29) are as described by the American Type Culture Collection (ATCC). A dinucleotide repeat polymorphism was used to examine LOH at the locus D14S43. PCR reactions were carried out using the primers 5'-TGGAACACTCAGGCGA-3' and 5'-CCAGAGCCACTTTCTAC-3' as described by Sharma et al. (1991) under the following conditions: A total volume of 25 ml containing 500 ng genomic DNA, 10 pmoles of each primer, 1.5 mM MgCl 2 , 200 mmoles dNTP's, 50 mM KCl, 10 mM Tris-HCl pH 8.3, 0.5 units of Taq polymerase (Cetus, Emeryville, CA) and 0.01% gelatin. Ampli®cation was carried out for 35 cycles with denaturation at 948C for 60 s, annealing at 558C for 60 s, and extension at 728C for 30 s in a thermal cycler made by MJ Devices. All probes for hybridization to Southern blots were labeled by random priming (Feinberg and Vogelstein, 1983) . Approximately 100 000 c.p.m. of probe was boiled and added to 10 ml of SDS-PEG (10% Sodium Dodecyl Sulfate, 7% Polyethylene Glycol) at 658C. This solution was added to the Hybond N + membranes (Amersham) and incubated overnight at 658C. Membranes were washed at 658C for 40 min in 0.16SSC and 0.1% SDS with two changes of the wash solution. Washed membranes were placed between sheets of Saran wrap and exposed to ®lm (Kodak XAR-5) at 7708C for varying lengths of time.
Karyotypes of peripheral blood lymphocytes were obtained from short term cultures using classical cytogenetic protocols. All probes were labeled with biotin by nick translation and suppression hybridization was performed as described Cremer et al., 1988) , with the following exceptions. Each hybridization reaction (10 ml volume) contained 300 ng of probe, 2.0 mg of human Cot-1 DNA (GIBCO BRL, Gaithersburg, MD) and 8.0 mg of salmon sperm DNA in a cocktail of 50% formamide, 10% Dextran Sulfate and 66SSC (pH 7.0). Probe and target DNA were denatured simultaneously under a sealed coverslip for 7 ± 10 min at 808C. Post hybridization washing and detection with 10 mg/ml FITC-Avidin DCS (Vector Laboratories, Burlingame, CA) were as described (Klinger et al., 1992) . All samples were counterstained with 100 ng/ml propidium iodide and analysed using a Zeiss Axioplan microscope equipped for epi¯uorescence. Single-exposure photographs were taken directly from the microscope with Kodak Gold 400 ®lm.
